Nr 546 week 7 Study guides, Class notes & Summaries
Looking for the best study guides, study notes and summaries about Nr 546 week 7? On this page you'll find 156 study documents about Nr 546 week 7.
All 156 results
Sort by
-
NR 546 WEEK 7 ADHD Medication Table (Updated)
- Exam (elaborations) • 3 pages • 2023
-
Available in package deal
-
- $14.99
- 6x sold
- + learn more
NR 546 WEEK 7 ADHD Medication Table (Updated). Methylphenidate (D/L) 
(Concerta, Ritalin) 
-Dopamine, norepinephrine 
inhibitor and releaser 
(DNRIRe), stimulant, FDA 
approved for ADHD in 
children and adults (ages vary 
based on formulations), 
narcolepsy. Off-label for 
treatmentresistant depression. 
Enhancement DA and NE in 
certain areas of the brain 
(dorsolateral prefrontal cortex, 
medial prefrontal cortex). 
Primary target symptoms: 
concentration, attention span, 
motor hyperactivity,...
-
NR 546 Week 7 ADHD Medication Table Latest.
- Other • 12 pages • 2023 Popular
- Available in package deal
-
- $12.99
- 4x sold
- + learn more
NR 546 Week 7 ADHD Medication Table Latest. 
Drug Name 
(include if IR, XR, 
ODT, LA) 
 
Indication (include 
approved ages) 
Neurotransmitter(s) 
Affected 
Target Symptoms 
Short-acting, 
intermediate-acting or 
long-acting. 
Duration of action, peak (if 
noted) 
Notable side effects /Patient education instructions 
Methylphenidate 
(D/L) 
(Concerta, Ritalin) 
Indication (include 
approved ages) 
Attention deficit 
hyperactivity disorder 
(ADHD) in children and 
adults (approved ages vary 
base...
-
NR 546 Week 7 ADHD Medication Table Latest.
- Other • 12 pages • 2023
- Available in package deal
-
- $11.99
- 2x sold
- + learn more
NR 546 Week 7 ADHD Medication Table Latest. 
Drug Name 
(include if IR, XR, 
ODT, LA) 
 
Indication (include 
approved ages) 
Neurotransmitter(s) 
Affected 
Target Symptoms 
Short-acting, 
intermediate-acting or 
long-acting. 
Duration of action, peak (if 
noted) 
Notable side effects /Patient education instructions 
Methylphenidate 
(D/L) 
(Concerta, Ritalin) 
Indication (include 
approved ages) 
Attention deficit 
hyperactivity disorder 
(ADHD) in children and 
adults (approved ages vary 
base...
-
NR 546 Week 7 ADHD Medication Table / NR 546 Week 7 ADHD Medication Table Latest UPDATE 2024 GRADED A+.
- Exam (elaborations) • 13 pages • 2024
-
Available in package deal
-
- $15.49
- 1x sold
- + learn more
NR 546 Week 7 ADHD Medication Table / NR 
546 Week 7 ADHD Medication Table Latest 
UPDATE 2024 GRADED A+.
-
NR 546 WEEK 7 ADHD Medication Table (2023/2024)
- Exam (elaborations) • 3 pages • 2023
- Available in package deal
-
- $8.49
- 2x sold
- + learn more
Drug Name 
(include if IR, XR, 
ODT, LA) 
Indication (include 
approved ages) 
Neurotransmitter(s) 
Affected 
Target Symptoms 
Short-acting, intermediateacting or long-acting. 
Duration of action, peak (if 
noted) 
Notable side effects /Patient education instructions 
Methylphenidate (D/L) 
(Concerta, Ritalin) 
-Dopamine, norepinephrine 
inhibitor and releaser 
(DNRIRe), stimulant, FDA 
approved for ADHD in 
children and adults (ages vary 
based on formulations), 
narcolepsy. Off-label for 
trea...
Get paid weekly? You can!
-
NR 546 Week 7 ADHD Medication Table Latest.
- Exam (elaborations) • 12 pages • 2024
-
- $19.99
- 1x sold
- + learn more
NR 546 Week 7 ADHD Medication Table Latest.
-
NR 546 WEEK 7 ADHD Medication Table | NR 546 Week 1-7 Quiz’s | Midterm Exam With Answers and Rationales | NR 546 Week 6 Addiction Medications Table | NR 546 Week 8 Neurotransmitter Table Chamberlain
- Package deal • 4 items • 2023
-
- $20.49
- 2x sold
- + learn more
NR 546 WEEK 7 ADHD Medication Table | NR 546 Week 1-7 Quiz’s | Midterm Exam With Answers and Rationales | NR 546 Week 6 Addiction Medications Table | NR 546 Week 8 Neurotransmitter Table Chamberlain

-
NR 546 WEEK 7 ADHD Medication Table
- Exam (elaborations) • 3 pages • 2023
- Available in package deal
-
- $14.99
- 2x sold
- + learn more
NR 546 WEEK 7 ADHD Medication Table. Drug Name 
(include if IR, XR, 
ODT, LA) 
Indication (include 
approved ages) 
Neurotransmitter(s) 
Affected 
Target Symptoms 
Short-acting, intermediateacting or long-acting. 
Duration of action, peak (if 
noted) 
Notable side effects /Patient education instructions 
Methylphenidate (D/L) 
(Concerta, Ritalin) 
-Dopamine, norepinephrine 
inhibitor and releaser 
(DNRIRe), stimulant, FDA 
approved for ADHD in 
children and adults (ages vary 
based on formulatio...
-
NR 546 Week 7 ADHD Medication Table
- Other • 1 pages • 2023
- Available in package deal
-
- $8.99
- 10x sold
- + learn more
Chamberlain NR 546 Week 7 ADHD Medication Table
-
NR 546 Week 7 Case Study: Child and Adolescent (Solved).
- Other • 6 pages • 2023
- Available in package deal
-
- $10.99
- 1x sold
- + learn more
NR 546 Week 7 Case Study: Child and Adolescent (Solved). 
Subjective Objective 
The client is a 7-year-old male accompanied by his 
mother and 9-year-old brother. 
Client’s Chief Complaints: 
“My son has endless energy, he can’t sit still. When 
he plays, he is too rough with other kids.” 
History of Present Illness 
This clint was previously diagnosed with attentiondeficit/hyperactivity disorder (ADHD). The school 
reports that he cannot stay seated, frequently calls 
out in class, is d...
That summary you just bought made someone very happy. Also get paid weekly? Sell your study resources on Stuvia! Discover all about earning on Stuvia